Health Canada
- Status: approved
🇨🇦 Bivalent OPV 4 week interval in Canada
Bivalent OPV 4 week interval (Bivalent OPV 4 week interval) regulatory status in Canada.
Marketing authorisation
Bivalent OPV 4 week interval in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Bivalent OPV 4 week interval approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Bivalent OPV 4 week interval in Canada?
International Centre for Diarrhoeal Disease Research, Bangladesh is the originator. The local marketing authorisation holder may differ — check the official source linked above.